U.K. Parliamentary Group, Pharmaceutical Leaders Call For Investment In Health Systems To Prevent MDR TB

Devex: Pharmaceutical leaders call for greater investment in health systems
“Aid agencies must invest more in strengthening health systems and infrastructure to avoid many millions of people losing their lives to multidrug-resistant tuberculosis by 2050, a group of U.K. members of Parliament said on World Tuberculosis Day. Their call to action is backed by senior figures in the pharmaceutical sector, who told Devex preventing a resurgent TB pandemic was not only dependent on drug development … [because] without better health infrastructure, investment in research and development is wasted as treatments are administered inadequately…” (Jóźwiak, 3/25).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.